1 / 7

Immunohistochemistry Market 2020-2026 Segment by Regions, Overall analysis, Type, Application and Sales

The study segments the Immunohistochemistry industry in light of major classification such as product type, potential markets, application, and end-user.

shabaz
Download Presentation

Immunohistochemistry Market 2020-2026 Segment by Regions, Overall analysis, Type, Application and Sales

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Immunohistochemistry Market To Reach USD 3,359.8 Million By 2026

  2. Market Summary Rising geriatric population, growing prevalence of chronic diseases, rapid technological developments in the immunohistochemistry industry, and increasing healthcare spending are key factors contributing to high CAGR of Immunohistochemistry market during the forecast period. Market Size – USD 1,736.4 million in 2018, Market Growth - CAGR of 8.6%, Market Trends – Product launches and research for advanced Immunohistochemistry According to the current analysis of Reports and Data, The global Immunohistochemistry market was valued at USD 1,736.4 million in 2018 and is expected to reach USD 3,359.8 million by the year 2026, growing at a CAGR of 8.6%.

  3. Our Approach Our Approach Market Summary Immunohistochemistry (IHC) has crucial applications in the field of tissue distribution of antigens by using monoclonal and polyclonal antibodies. It is used for cancer diagnosis, because it determines the presence of tumor antigens. It is a technique which combines immunological, anatomical, and biochemical processes to identify tissue components by the interaction of target antigens with specific antibodies that are tagged by a label. Immunohistochemistry used by public and private organizations to check localization and distribution of cellular components within the cells. Immunohistochemistry is being applied in many other areas. Immunohistochemistry is widely used to predict therapeutic response in two important tumors, i.e. carcinoma of breast and prostate. Both these tumors are under the growth regulation of the hormones estrogen and androgen, respectively. The specific receptors for these growth regulating hormones are located on respective tumor cells Request for a sample of this research report @ https://www.reportsanddata.com/sample-enquiry-form/2198

  4. Our Approach Our Approach Market Summary Further key findings from the report suggest • Immunohistochemistry finds its application in diagnosing cancer types, chronic diseases, neurological diseases and also helps to determine the presence of benign or malignant tumor. Immunohistochemistry is more advantageous than traditional enzyme staining techniqueas it involves specific antigen-antibody reactions. It is widely used in clinical diagnostics and medical research laboratories. Rapid increase in healthcare spending and a changing healthcare infrastructure with better medical practice and care facilities, rise in geriatric population leads to increased need for Immunohistochemistry techniques are the driving factors of the market Antibody segment accounts for largest market share of 41.2% due to rising regulatory approvals for therapeutic antibody products and is expected to show more growth during the forecast period To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report- detail/immunohistochemistry-market • • •

  5. Our Approach Our Approach Market Summary Key participants include Abcam plc; Agilent Technologies; Bio-Rad Laboratories, Inc.; Cell Signaling Technology, Inc.; Danaher Corporation; Merck KGaA; PerkinElmer, Inc.; and Thermo Fisher Scientific, Inc. Type (Revenue, USD Million; 2016–2026) Antibodies Primary Antibodies Secondary Antibodies Equipment Slide Staining Systems Tissue Microarrays Tissue Processing Systems Slide Scanners Others

  6. Our Approach Our Approach Market Summary Application (Revenue, USD Million; 2016–2026) Diagnostics Cancer Infectious Diseases Cardiovascular Diseases Autoimmune Diseases Diabetes Mellitus Nephrological Diseases Drug Testing Order Now: https://www.reportsanddata.com/checkout-form/2198

  7. About Us Our Approach Our Approach About Us About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related